Evidence map›Paper›PMID 34049903›Full record

SynthesisBMJ open2021

Association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19 including clinical course, morbidity and mortality outcomes? A systematic review.

Amy Grove, Osemeke Osokogu, Lena Al-Khudairy, Amin Mehrabian, Mandana Zanganeh, Anna Brown, Rachel Court, Sian Taylor-Phillips, Olalekan A Uthman, Noel McCarthy and 2 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Does vitamin D supplementation reduce COVID-19 severity?: a systematic review.QJM : monthly journal of the Association of Physicians · 2022
    Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Essential metals, vitamins and antioxidant enzyme activities in COVID-19 patients and their potential associations with the disease severity.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2022
    Article
  13. Article
  14. Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury.International journal of biological sciences · 2022
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Amy GroveDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK A.L.Grove@warwick.ac.uk.ORCID 0000-0002-8027-7274
Osemeke OsokoguDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK.
Lena Al-KhudairyDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK.
Amin MehrabianDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK.ORCID 0000-0002-8879-7565
Mandana ZanganehDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK.
Anna BrownDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK.
Rachel CourtDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK.
Sian Taylor-PhillipsDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK.ORCID 0000-0002-1841-4346
Olalekan A UthmanWarwick-Centre for Applied Health Research (WCAHRD), University of Warwick, Coventry, UK.ORCID 0000-0002-8567-3081
Noel McCarthyDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK.
Sudhesh KumarWarwick Medical School, The University of Warwick, Coventry, UK.
Aileen ClarkeDivision of Health Sciences, Warwick Medical School, The University of Warwick, Coventry, UK.
University of Warwick · GBMashhad University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo systemically review and critically appraise published studies of the association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19, including clinical course, morbidity and mortality outcomes.

designSystematic review. DATA SOURCES: MEDLINE (OVID), Embase (OVID), Cochrane Central Register of Controlled Trials, MedRxiv and BioRxiv preprint databases. COVID-19 databases of the WHO, Cochrane, CEBM Oxford and Bern University up to 10 June 2020. STUDY SELECTION: Studies that assessed vitamin D supplementation and/or low serum vitamin D in patients acutely ill with, or at risk of, severe betacoronavirus infection (SARS-CoV, MERS-CoV, SARS-CoV-2). DATA EXTRACTION: Two authors independently extracted data using a predefined data extraction form and assessed risk of bias using the Downs and Black Quality Assessment Checklist.

resultsSearches elicited 449 papers, 59 studies were eligible full-text assessment and 4 met the eligibility criteria of this review. The four studies were narratively synthesised and included (1) a cross-sectional study (n=107) suggesting an inverse association between serum vitamin D and SARS-CoV-2; (2) a retrospective cohort study (348 598 participants, 449 cases) in which univariable analysis showed that vitamin D protects against COVID-19; (3) an ecological country level study demonstrating a negative correlation between vitamin D and COVID-19 case numbers and mortality; and (4) a case-control survey (n=1486) showing cases with confirmed/probable COVID-19 reported lower vitamin D supplementation. All studies were at high/unclear risk of bias.

conclusionThere is no robust evidence of a negative association between vitamin D and COVID-19. No relevant randomised controlled trials were identified and there is no robust peer-reviewed published evidence of association between vitamin D levels and severity of symptoms or mortality due to COVID-19. Guideline producers should acknowledge that benefits of vitamin D supplementation in COVID-19 are as yet unproven despite increasing interest.

Indexed as

COVID-19SARS-CoV-2Cross-Sectional StudiesDietary SupplementsHumansMorbidityRetrospective StudiesVitamin DVitamin DCOVID-19nutrition & dieteticspublic health

Identifiers

PMID34049903
PMCPMC8166456
OpenAlexW3164219348

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.